Project Grant K01DA060309
Award Date
1/15/25
Completion Date
12/31/29
Dollars Obligated
$194K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Burlington, VT 05401, USA
Similar Awards
This $1,076,018 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a randomized clinical trial of DCH-003, a digital therapeutic developed by Dynamicare Health Inc. to deliver contingency management (CM) for the treatment of stimulant use disorder. The study aims to evaluate the efficacy of DCH-003, which automates CM through remote, self-administered saliva tests and integrates evidence-based therapy...
This K02 independent scientist award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will enhance the recipient's research career in implementation science to address the opioid overdose crisis from the emergency department (ED) setting. With $123,930 in funding from June 2024 to May 2028, the award will enable the recipient to: Evaluate implementation outcomes across partners engaged in the recipient's ongoing R01-funded...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $210,600 over a 5-year period from July 1, 2024 to June 30, 2029. The award will support Dr. Michael Incze, a general internist and addiction medicine physician, to design, refine, and pilot test an interdisciplinary "Addiction Care Transition (INTACT) Team" intervention. This intervention aims to improve transitions to primary...
This $200,772 Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to test strategies for implementing and evaluating harm reduction-focused smart vending machines (SVMs) that deliver naloxone, fentanyl test strips, and other public health items in communities impacted by substance use disorders and overdoses. The five-year study, led by Pennsylvania State University's Milton S. Hershey...
The National Institute on Drug Abuse (NIDA) awarded a $2,427,126 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Washington State University. The grant, titled "Strength in Healing: Indigenous Community-Led Strategies to Treat Stimulant Use", aims to rapidly implement culturally responsive interventions for stimulant use disorders among American Indian and Alaska Native (AI/AN) populations, who experience disproportionately high rates of fatal...
This $197,748 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to develop and pilot an enhanced low-dose buprenorphine initiation (LDI) program to improve treatment outcomes for individuals with opioid use disorder (OUD), especially those using fentanyl. The key objectives of this 4-year project are to: 1) identify barriers to successful LDI completion through qualitative interviews, 2)...
The National Institute on Drug Abuse (NIDA) awarded a $390,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan. The grant, titled "Cultivating Recovery: A Pilot Study of Digital Contingency Management for Co-Occurring Opioid and Alcohol Use Disorder," will fund a mixed-methods randomized pilot trial to test the feasibility and acceptability of a digital contingency management intervention for Medicaid...
This $180,896 federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to use machine learning techniques to analyze integrated clinical and geosocial data to inform the design of a clinical decision support system (CDSS) to reduce the risk of stimulant therapy. The key products/services to be delivered under this 5-year award, starting July 2024, include: Retrospective analysis of electronic...
The National Institute on Drug Abuse (NIDA) awarded a $177,170 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMass Medical) for the "Implementation of Medications for Opioid Use Disorder in Massachusetts Jails" project. The funding will support a mixed-methods study to analyze the implementation of medications for opioid use disorder (MOUD) treatment in Massachusetts county jails. The research aims...
This National Institute on Drug Abuse (NIDA) Project Grant award for $1,126,100 aims to refine and pilot the R3 Supervision Strategy in substance use disorder (SUD) treatment programs. The funding, awarded under CFDA 93.279 - Drug Use and Addiction Research Programs, will enable the University of Arkansas for Medical Sciences (UAMS) to partner with SUD providers to modify and refine the evidence-based R3 supervision strategy for SUD settings. UAMS will then conduct two pilot cycles with 8...